{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:06:48Z","timestamp":1791389208806,"version":"4.3.3"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008676","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000}}],"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"General Research Fund of Research Grants Council","award":["Project number: 16204519"],"award-info":[{"award-number":["Project number: 16204519"]}]},{"name":"Hong Kong PhD Fellowship Scheme","award":["PF15-10255"],"award-info":[{"award-number":["PF15-10255"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008676","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T18:35:07Z","timestamp":1600713307000},"page":"e0008676","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6086-0307","authenticated-orcid":true,"given":"Syed Faraz","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Quadeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1467-421X","authenticated-orcid":true,"given":"John P.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8086-2545","authenticated-orcid":true,"given":"Matthew R.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"pntd.0008676.ref001","unstructured":"UN fact sheets. Dengue and severe dengue. 2019 [cited 14 Oct 2019]. Available: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue"},{"key":"pntd.0008676.ref002","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.aac5017","article-title":"Dengue viruses cluster antigenically but not as discrete serotypes","volume":"349","author":"LC Katzelnick","year":"2015","journal-title":"Science"},{"key":"pntd.0008676.ref003","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","volume":"393","author":"A Wilder-Smith","year":"2019","journal-title":"Dengue. Lancet"},{"key":"pntd.0008676.ref004","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(16)00026-8","article-title":"The global burden of dengue: an analysis from the Global Burden of Disease Study 2013","volume":"16","author":"JD Stanaway","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"pntd.0008676.ref005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"S Bhatt","year":"2013","journal-title":"Nature"},{"key":"pntd.0008676.ref006","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tim.2013.12.011","article-title":"Global spread of dengue virus types: mapping the 70 year history","volume":"22","author":"JP Messina","year":"2014","journal-title":"Trends Microbiol"},{"key":"pntd.0008676.ref007","doi-asserted-by":"crossref","first-page":"e1760","DOI":"10.1371\/journal.pntd.0001760","article-title":"Refining the global spatial limits of dengue virus transmission by evidence-based consensus.","volume":"6","author":"OJ Brady","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008676.ref008","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/infdis\/jiw423","article-title":"Current status of dengue therapeutics research and development","volume":"215","author":"JGH Low","year":"2017","journal-title":"J Infect Dis"},{"key":"pntd.0008676.ref009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue.","volume":"385","author":"MG Guzman","year":"2015","journal-title":"Lancet"},{"key":"pntd.0008676.ref010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"S Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"pntd.0008676.ref011","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri3916","article-title":"New insights into the immunopathology and control of dengue virus infection","volume":"15","author":"G Screaton","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"pntd.0008676.ref012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"RM Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"pntd.0008676.ref013","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune response to dengue and zika","volume":"36","author":"A Elong Ngono","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"pntd.0008676.ref014","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8 + T cells","volume":"182","author":"LE Yauch","year":"2009","journal-title":"J Immunol"},{"key":"pntd.0008676.ref015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ebiom.2016.10.006","article-title":"Protective role of cross-reactive CD8 T cells against dengue virus infection.","volume":"13","author":"A Elong Ngono","year":"2016","journal-title":"EBioMedicine"},{"key":"pntd.0008676.ref016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/jir.2017.0106","article-title":"T cell immunity to zika and dengue viral infections","volume":"37","author":"J Wen","year":"2017","journal-title":"J Interf Cytokine Res"},{"key":"pntd.0008676.ref017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/14760584.2016.1116948","article-title":"T cell immunity to dengue virus and implications for vaccine design","volume":"15","author":"L. Rivino","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"pntd.0008676.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01424","article-title":"A modified mRNA vaccine targeting immunodominant NS epitopes protects against dengue virus infection in HLA class I transgenic mice","volume":"10","author":"C Roth","year":"2019","journal-title":"Front Immunol"},{"key":"pntd.0008676.ref019","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/infdis\/jiv258","article-title":"CD8 + T-cell responses in flavivirus-naive individuals following immunization with a live-attenuated tetravalent dengue vaccine candidate","volume":"212","author":"H Chu","year":"2015","journal-title":"J Infect Dis"},{"key":"pntd.0008676.ref020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","article-title":"Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYDTM vaccine?","volume":"15","author":"SS Whitehead","year":"2016","journal-title":"Expert Rev Vaccines."},{"key":"pntd.0008676.ref021","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/21645515.2016.1261770","article-title":"Vaccines licensed and in clinical trials for the prevention of dengue.","volume":"13","author":"J Torresi","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"pntd.0008676.ref022","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3389\/fimmu.2019.01316","article-title":"Cross-reactive T cell immunity to dengue and zika viruses: New insights into vaccine development","volume":"10","author":"A Elong Ngono","year":"2019","journal-title":"Front Immunol"},{"key":"pntd.0008676.ref023","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1128\/JVI.00155-08","article-title":"Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination","volume":"82","author":"R Holtappels","year":"2008","journal-title":"J Virol"},{"key":"pntd.0008676.ref024","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"T Duangchinda","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"pntd.0008676.ref025","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/cei.12373","article-title":"Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes","volume":"177","author":"P Piazza","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"pntd.0008676.ref026","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1128\/JVI.02892-15","article-title":"Immunodominant dengue virus-specific CD8 + T cell responses are associated with a memory PD-1 + phenotype","volume":"90","author":"R de Alwis","year":"2016","journal-title":"J Virol"},{"key":"pntd.0008676.ref027","doi-asserted-by":"crossref","first-page":"11383","DOI":"10.1128\/JVI.01108-14","article-title":"Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection","volume":"88","author":"D Weiskopf","year":"2014","journal-title":"J Virol"},{"key":"pntd.0008676.ref028","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8 + T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"D Weiskopf","year":"2015","journal-title":"J Infect Dis"},{"key":"pntd.0008676.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.01309","article-title":"Global assessment of dengue virus-specific CD 4+ T Cell responses in dengue-endemic areas","volume":"8","author":"A Grifoni","year":"2017","journal-title":"Front Immunol"},{"key":"pntd.0008676.ref030","doi-asserted-by":"crossref","first-page":"e2462","DOI":"10.1371\/journal.pntd.0002462","article-title":"The Nicaraguan pediatric dengue cohort study: Incidence of inapparent and symptomatic dengue virus infections, 2004\u20132010.","volume":"7","author":"A Gordon","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008676.ref031","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"D Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pntd.0008676.ref032","doi-asserted-by":"crossref","first-page":"e0006540","DOI":"10.1371\/journal.pntd.0006540","article-title":"Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection","volume":"12","author":"DT Wijeratne","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"pntd.0008676.ref033","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.4049\/jimmunol.1401597","article-title":"CD8 + T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice","volume":"193","author":"RM Zellweger","year":"2014","journal-title":"J Immunol"},{"key":"pntd.0008676.ref034","article-title":"Dengue vaccine\u2013induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.","volume":"2","author":"JH Lam","year":"2017","journal-title":"JCI Insight."},{"key":"pntd.0008676.ref035","article-title":"Conservation and variability of dengue virus proteins: Implications for vaccine design.","volume":"2","author":"AM Khan","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008676.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2011.00069","article-title":"Conservation analysis of dengue virus T-cell epitope-based vaccine candidates using peptide block entropy","volume":"2","author":"L. Olsen","year":"2011","journal-title":"Front Immunol"},{"key":"pntd.0008676.ref037","article-title":"Identification of conserved and HLA promiscuous DENV3 T-cell epitopes.","volume":"7","author":"EJM Nascimento","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"pntd.0008676.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.14.1.1","article-title":"Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology","volume":"14","author":"J Sloan-Lancaster","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"pntd.0008676.ref039","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4049\/jimmunol.165.1.280","article-title":"Altered peptide ligand-mediated TCR antagonism can be modulated by a change in a single amino acid residue within the CDR3 beta of an MHC class I-restricted TCR","volume":"165","author":"AM Kalergis","year":"2000","journal-title":"J Immunol"},{"key":"pntd.0008676.ref040","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2019.00827","article-title":"Quantitative prediction of the landscape of T cell epitope immunogenicity in sequence space","volume":"10","author":"M Ogishi","year":"2019","journal-title":"Front Immunol"},{"key":"pntd.0008676.ref041","unstructured":"European Centre for disease prevention and. Dengue worldwide overview. 2019 [cited 29 Nov 2019]. Available: https:\/\/www.ecdc.europa.eu\/en\/dengue-monthly"},{"key":"pntd.0008676.ref042","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: An open bioinformatics database and analysis resource for virology research","volume":"40","author":"BE Pickett","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"pntd.0008676.ref043","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: Improvements in performance and usability","volume":"30","author":"K Katoh","year":"2013","journal-title":"Mol Biol Evol"},{"key":"pntd.0008676.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01568","article-title":"Characterization of magnitude and antigen specificity of HLA-DP, DQ, and DRB3\/4\/5 restricted DENV-specific CD4+ T cell responses","volume":"10","author":"A Grifoni","year":"2019","journal-title":"Front Immunol"},{"key":"pntd.0008676.ref045","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update.","volume":"47","author":"R Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pntd.0008676.ref046","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"FF Gonz\u00e1lez-Galarza","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"pntd.0008676.ref047","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fimmu.2014.00093","article-title":"T-cell immunity to infection with dengue virus in humans","volume":"5","author":"D Weiskopf","year":"2014","journal-title":"Front Immunol"},{"key":"pntd.0008676.ref048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.02125","article-title":"Human T cell response to dengue virus infection","volume":"10","author":"Y Tian","year":"2019","journal-title":"Front Immunol"},{"key":"pntd.0008676.ref049","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2009.05.021","article-title":"CD8+ T cell immunodominance shifts during the early stages of acute LCMV infection independently from functional avidity maturation","volume":"390","author":"H-P Rau\u00e9","year":"2009","journal-title":"Virology"},{"key":"pntd.0008676.ref050","doi-asserted-by":"crossref","first-page":"12904","DOI":"10.1093\/nar\/gkx1127","article-title":"NS3 helicase from dengue virus specifically recognizes viral RNA sequence to ensure optimal replication","volume":"45","author":"CMD Swarbrick","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"pntd.0008676.ref051","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1074\/jbc.M117.775643","article-title":"Serotype-specific interactions among functional domains of dengue virus 2 nonstructural proteins (NS) 5 and NS3 are crucial for viral RNA replication.","volume":"292","author":"T Teramoto","year":"2017","journal-title":"J Biol Chem"},{"key":"pntd.0008676.ref052","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/B978-0-12-815422-9.00014-0","article-title":"Dengue virus polymerase.","author":"VM Patil","year":"2019","journal-title":"Viral Polymerases."},{"key":"pntd.0008676.ref053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1005451","article-title":"Dengue virus nonstructural protein 5 (NS5) assembles into a dimer with a unique methyltransferase and polymerase interface.","volume":"12","author":"VJ Klema","year":"2016","journal-title":"PLoS Pathog"},{"key":"pntd.0008676.ref054","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2017.01.041","article-title":"Sequence, structure and function relationships in flaviviruses as assessed by evolutive aspects of its conserved non-structural protein domains","volume":"492","author":"NJ da Fonseca","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"pntd.0008676.ref055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","article-title":"The dengue virus NS5 protein as a target for drug discovery","volume":"119","author":"SP Lim","year":"2015","journal-title":"Antiviral Res"},{"key":"pntd.0008676.ref056","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-12-809712-0.00007-1","article-title":"Flavivirus NS2B\/NS3 protease: Structure, function, and inhibition.","author":"Z Li","year":"2017","journal-title":"Viral Proteases and Their Inhibitors."},{"key":"pntd.0008676.ref057","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development","volume":"118","author":"D Luo","year":"2015","journal-title":"Antiviral Res"},{"key":"pntd.0008676.ref058","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/JVI.01788-07","article-title":"Crystal structure of the NS3 protease-helicase from dengue virus","volume":"82","author":"D Luo","year":"2008","journal-title":"J Virol"},{"key":"pntd.0008676.ref059","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/1381612823666170913163904","article-title":"Development of peptide vaccines in dengue","volume":"24","author":"K Reginald","year":"2018","journal-title":"Curr Pharm Des"},{"key":"pntd.0008676.ref060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/JVI.02129-14","article-title":"The human CD8 + T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"D Weiskopf","year":"2015","journal-title":"J Virol"},{"key":"pntd.0008676.ref061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01778","article-title":"Assessing the diversity and stability of cellular immunity generated in response to the candidate live-attenuated dengue virus vaccine TAK-003.","volume":"10","author":"AT Waickman","year":"2019","journal-title":"Front Immunol."},{"key":"pntd.0008676.ref062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza a vaccine, MVA-NP+M1","volume":"52","author":"TK Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"pntd.0008676.ref063","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10875-011-9632-5","article-title":"Safety and immunogenicity of multimeric-001\u2014A novel universal influenza vaccine","volume":"32","author":"J Atsmon","year":"2012","journal-title":"J Clin Immunol"},{"key":"pntd.0008676.ref064","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/CVI.00098-15","article-title":"A synthetic influenza virus vaccine induces a cellular immune response that correlates with reduction in symptomatology and virus shedding in a randomized phase Ib live-virus challenge in humans","volume":"22","author":"O Pleguezuelos","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"pntd.0008676.ref065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-1-59745-450-6_29","article-title":"T-cell epitope processing (The epitope flanking regions matter).","author":"AN Martinez","year":"2009","journal-title":"Methods in Molecular Biology"},{"key":"pntd.0008676.ref066","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.0105-2896.2010.00897.x","article-title":"Heterologous immunity between viruses","volume":"235","author":"RM Welsh","year":"2010","journal-title":"Immunol Rev"},{"key":"pntd.0008676.ref067","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0161-5890(94)90155-4","article-title":"Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity","volume":"31","author":"MCW Feltkamp","year":"1994","journal-title":"Mol Immunol"},{"key":"pntd.0008676.ref068","doi-asserted-by":"crossref","first-page":"e1002041","DOI":"10.1371\/journal.ppat.1002041","article-title":"Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges","volume":"7","author":"E-J Im","year":"2011","journal-title":"PLoS Pathog."},{"key":"pntd.0008676.ref069","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1128\/JVI.00981-12","article-title":"Memory CD8 + T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease","volume":"86","author":"S Remakus","year":"2012","journal-title":"J Virol"},{"key":"pntd.0008676.ref070","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.4049\/jimmunol.1001606","article-title":"Responses against a subdominant CD8 + T cell epitope protect against immunopathology caused by a dominant epitope","volume":"185","author":"TJ Ruckwardt","year":"2010","journal-title":"J Immunol"},{"key":"pntd.0008676.ref071","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ni1281","article-title":"Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes","volume":"7","author":"N Frahm","year":"2006","journal-title":"Nat Immunol"},{"key":"pntd.0008676.ref072","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses","volume":"19","author":"JL Slon Campos","year":"2018","journal-title":"Nat Immunol"},{"key":"pntd.0008676.ref073","first-page":"1","article-title":"Cross-reactive immunity among flaviviruses","volume":"11","author":"APS Rathore","year":"2020","journal-title":"Front Immunol."},{"key":"pntd.0008676.ref074","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"A Grifoni","year":"2020","journal-title":"Cell Host Microbe."},{"key":"pntd.0008676.ref075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies.","volume":"12","author":"SF Ahmed","year":"2020","journal-title":"Viruses"},{"key":"pntd.0008676.ref076","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/s41596-020-0358-9","article-title":"COVIDep: A web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2.","volume":"15","author":"SF Ahmed","year":"2020","journal-title":"Nat Protoc."},{"key":"pntd.0008676.ref077","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/jir814","article-title":"Conserved MHC class I\u2013presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-Cell response","volume":"205","author":"JS Testa","year":"2012","journal-title":"J Infect Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008676","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T17:58:57Z","timestamp":1601575137000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008676"}},"subtitle":[],"editor":[{"given":"Daniela","family":"Weiskopf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":77,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008676","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0008676","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]}}}